Prevalence of Gastroesophageal reflux disease (GERD) in patients with upper gastrointestinal tract symptoms in Egypt - GERD Q NIS

Study identifier:NIS-GEG-XXX-2012/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Prevalence of Gastroesophageal reflux disease (GERD) in patients with upper gastrointestinal tract symptoms in Egypt

Medical condition

patients with upper gastro-intestinal symptoms

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

3170

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Jul 2012
Primary Completion Date: 01 Jul 2014
Study Completion Date: 01 Jul 2014

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Oct 2014 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria